	Les Charges D'Exploitation		Date
Alnylam Pharmaceuticals	USD 881.04M	91.16M	2025-09
Celltrion	KRW 724.99B	6B	2025-09
Cspc Pharmaceutical	CNY 5.4B	298.41M	2025-09
Dianthus Therapeutics	USD 40.68M	5.56M	2025-09
Divis Laboratories Ltd	INR 19.4B	1.47B	2025-09
Gilead Sciences	USD 4.26B	95M	2025-09
Ionis Pharmaceuticals	USD 316.9M	4.69M	2025-09
Kangmei Pharma	CNY 1.39B	144.29M	2025-09
Knight Therapeutics	CAD 89.06M	2.02M	2024-09
Laboratorios Farma	EUR 313.62M	17.98M	2023-12
MacroGenics	USD 67M	8M	2025-09
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 10.02M	9.78M	2025-06
Neuren Pharmaceuticals	AUD 8.69M	8.72M	2025-06
Organigram Holdings	CAD 108.11M	17.03M	2025-09
Pfizer	USD 92.8B	82.47B	2025-09
Pharma Mar	EUR 39.62M	7.34M	2025-09
Qiagen NV	USD 395.29M	2.28M	2025-09
Roche Holding	CHF 21.01B	10.84B	2025-12
Sanofi	EUR 10.51B	1.21B	2025-12
Sarepta Therapeutics	USD 462.23M	33.28M	2025-09
Sartorius	EUR 693.1M	29.4M	2025-09
Sino Biopharmaceutical	CNY 12.39B	1.26B	2025-06
Takeda	JPY 1.02T	400.98B	2025-12
Tilray	USD 237.52M	17.34M	2025-09
Zz Pientze Pharmaceu	CNY 1.55B	129.66M	2025-09

Tectonic Therapeutic Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.